Table 1.
The number of Genotype-Tissue Expression (GTEx) and The Cancer Genome Atlas (TCGA) samples used in the study 1.
| Organ/Cancer Tissue Type | GTEX | TCGA | Total |
|---|---|---|---|
| Adrenal_Gland/PCPG | 128 | 185 | 313 |
| Brain/LGG | 105 | 527 | 632 |
| /GBM | 173 | 173 | |
| Breast/BRCA | 179 | 1253 | 1432 |
| Colon/COAD | 308 | 455 | 763 |
| Esophagus/ESCA | 273 | 195 | 468 |
| Leukemia/LAML | 337 | 173 | 510 |
| Liver/LIHC | 110 | 422 | 532 |
| Lung/LUAD | 288 | 598 | 886 |
| /LUSC | 551 | 551 | |
| Pancreas/PAAD | 167 | 183 | 350 |
| Prostate/PRAD | 100 | 556 | 656 |
| Stomach/STAD | 175 | 451 | 626 |
| Thyroid/THCA | 280 | 571 | 851 |
| Total | 2450 | 6293 | 8743 |
1 The number of healthy samples is listed under the GTEx column and the number of tumor samples is listed under TCGA column. Acronyms of cancer tissue types: BRCA = breast invasive carcinoma, COAD = colon adenocarcinoma, ESCA = esophageal carcinoma, GBM = glioblastoma multiforme, LAML = acute myeloid leukemia, LGG = brain lower grade glioma, LIHC = liver hepatocellular carcinoma, LUAD = lung adenocarcinoma, LUSC = lung squamous cell carcinoma, PAAD = pancreatic adenocarcinoma, PCPG = pheochromocytoma and paraganglioma, PRAD = prostate adenocarcinoma, STAD = stomach adenocarcinoma, and THCA = thyroid carcinoma.